Biostatistics and Research Decision Sciences, Merck & Co., Inc., North Wales, Pennsylvania, USA.
In the published article entitled “Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trials” (DOI:10.1002/sim.8750), the Figures 5, 7, 5, 7, and 9 in the first published version should appear as follows:
FIGURE 5
Open in figure viewerPowerPoint
Results from 5-STAR Step 4 and Step 5 for Example 1. Top: Kaplan-Meier curves by treatment within each formed risk stratum. Bottom: forest plot showing stratum-level results for each formed risk stratum as well as the overall (ie, stratum-averaged) result. HR, hazard ratio, with HR < 1 favoring the test treatment; TR, time ratio, with TR > 1 favoring the test treatment [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 7
Open in figure viewerPowerPoint
Results from 5-STAR Step 4 and Step 5 for Example 2. Top: Kaplan-Meier curves by treatment within each formed risk stratum. Bottom: forest plot showing stratum-level results for each formed risk stratum as well as the overall (ie, stratum-averaged) result. HR, hazard ratio, with HR < 1 favoring the test treatment; TR , time ratio, with TR > 1 favoring the test treatment [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 9
Open in figure viewerPowerPoint
Results from 5-STAR Step 4 and Step 5 for Example 3. Top: Kaplan-Meier curves by treatment within each formed risk stratum. Bottom: forest plot showing stratum-level results for each formed risk stratum as well as the overall (ie, stratum-averaged) result. HR, hazard ratio, with HR < 1 favoring the test treatment; TR, time ratio, with TR > 1 favoring the test treatment [Colour figure can be viewed at wileyonlinelibrary.com]
京公网安备 11010802027423号